Used in pharmaceutical research as a key intermediate in the synthesis of cannabinoid receptor modulators. Its unique cyclopropyl-difluoro structure enhances metabolic stability and binding affinity, making it valuable in developing CNS-targeted drugs. Also employed in the preparation of analogs for structure-activity relationship (SAR) studies, particularly in pain management and neurological disorder therapies. The hydroxyl group allows for easy derivatization, enabling attachment to other pharmacophores in multi-step synthetic routes.